Pharmaceutical & Biotech
BIO 2005 Update: Seeking Understanding From Washington Lawmakers and the World
Beyond the medical hope offered by biotech, every state in the union and virtually every country in the world seek to be chosen for the construction of the industry's research and manufacturing facilities.
Released Tuesday, June 21, 2005
Reported by Annette Kreuger, Industrialinfo.com (Industrial Information Resources, Incorporated; Houston, Texas). The annual Biotechnology Industry Organization (BIO) meeting in Philly is proving to be much more than the sum of its many colorful parts. Amid the over 1,500 booths with interactive displays and hundreds of breakout business sessions and forums, the industry as a whole is determined to define itself and the vital importance of what it offers. The title of Monday's opening plenary lunch session was a bold indication of just how serious they are in that mission - "Saving the World: The Future of Global Drug Development"
Newly installed BIO president and CEO Jim Greenwood, a former social worker and ten-year veteran of the U.S. House of Representatives, who also served another three years as Chairman of the Energy and Commerce Committee Subcommittee on Oversight and Investigation, used Monday's luncheon to launch a new industry video -- "Great New Frontier". The short film explores the impact biotechnology has on our lives and its potential to do even more. Greenwood discussed the general lack of understanding in regard to the biotech industry as a whole and the befuddlement of his former colleagues in Washington as to what it means.
"Oh, stem cell research..." was the typical response received from his fellow lawmakers when Greenwood explained he was leaving to take the helm of BIO. Frustrated that few understood the potential for saving scores of lives across the globe and for delivering future generations from suffering today's diseases, the industry made the video to generally illustrate the industry's impact. Available for viewing at www.bio.org, the film features people whose lives have been saved by biotech drugs. It touches on the far-reaching effects of research beyond medicine, encompassing world hunger and energy solutions.
Beyond the medical hope offered by biotech, every state in the union and virtually every country in the world seek to be chosen for the construction of the industry's research and manufacturing facilities. As discussed in Industrialinfo.com's 2005 North American Pharmaceutical-Biotech Forecast, these projects bring the promise of high-paying jobs, offering an average annual salary topping $65,000. With the manufacturing process clean by nature, the red carpet is being rolled out to every company that is even considering building a new lab or plant. From Russia, with its first booth ever at BIO, to the heartland of America, everyone is not so subtly shouting, "Choose us"!
Big Pharma's presence, underscored by industry giant Pfizer's serving as sponsor of the luncheon sessions, made evident that the line between the pharmaceutical and biotech industries continues to fade. Moderated by Fox News host, Morton Kondracke, leaders from Celgene, AstraZeneca, and Wyeth Pharmaceuticals joined Pfizer's Dr. Peter Corr, Senior Vice President of Science and Technology, to discuss trends in drug development. Particular focus was placed on filling unmet medical needs on a global basis.
Industrial Information Resources (IIR) is a Marketing Information Service company that has been doing business for over 22 years. IIR is respected as a leader in providing comprehensive market intelligence pertaining to the industrial processing, heavy manufacturing, and energy-related industries throughout the world.
Want More IIR News Intelligence?
Make us a Preferred Source on Google to see more of us when you search.
Add Us On GoogleAsk Us
Have a question for our staff?
Submit a question and one of our experts will be happy to assist you.
Forecasts & Analytical Solutions
Where global project and asset data meets advanced analytics for smarter market sizing and forecasting.
Explore Our SolutionsRelated Articles
-
Eli Lilly Advances U.S. Manufacturing BuildoutSeptember 24, 2026
-
U.S. States Planning the Most Industrial Spending in 2027September 08, 2026
-
U.S. Megaprojects to Watch for in 2027September 01, 2026
-
GLP-1 Drugs Drive Pharma Construction WaveAugust 27, 2026
-
El Niño Shapes North America Fall, Winter OutlookAugust 27, 2026
PECWeb Global Market Intelligence Platform
Identify opportunities, anticipate change, and execute with confidence. PECWeb connects the industrial intelligence you need, from projects and assets to operational events, all in one platform.
Discover PecwebIndustry Intel
-
North America Refining 2026: New Pipelines to PADD 5Podcast Episode / Oct 2, 2026
-
Biomanufacturing Onshoring 2026: GLP-1 Drives CapexPodcast Episode / Oct 2, 2026
-
2026 US Data Center Outlook: Power, Land & CoolingPodcast Episode / Sep 18, 2026
-
2026 Global Power Demand Outlook: Gas, Nuclear & RenewablesPodcast Episode / Sep 18, 2026
-
2026 Oil & Gas CapEx Outlook: Middle East, LNG & PermianPodcast Episode / Sep 4, 2026